1. Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer. (3rd April 2017) Authors: Gharaibeh, Mahdi; McBride, Ali; Bootman, J. Lyle; Patel, Hitendra; Abraham, Ivo Journal: Journal of medical economics Issue: Volume 20:Number 4(2017) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗